NASDAQ:MTBC - Medical Transcription Billing Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.48 -0.06 (-1.32 %)
(As of 01/16/2019 05:23 AM ET)
Previous Close$4.54
Today's Range$4.45 - $4.63
52-Week Range$2.86 - $5.65
Volume50,800 shs
Average Volume47,410 shs
Market Capitalization$53.23 million
P/E Ratio-34.46
Dividend YieldN/A
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
SectorComputer and Technology
Current SymbolNASDAQ:MTBC


Current Ratio1.70
Quick Ratio1.65


Sales & Book Value

Annual Sales$31.81 million
Price / Sales1.67
Cash Flow$0.2451 per share
Price / Cash Flow18.28
Book Value$1.76 per share
Price / Book2.55


Net Income$-5,560,000.00
Net Margins-6.62%
Return on Assets-6.61%


Market Cap$53.23 million
OptionableNot Optionable

Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions

What is Medical Transcription Billing's stock symbol?

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

How were Medical Transcription Billing's earnings last quarter?

Medical Transcription Billing Corp (NASDAQ:MTBC) issued its quarterly earnings data on Wednesday, November, 7th. The technology company reported ($0.25) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.23) by $0.02. The technology company earned $17.05 million during the quarter, compared to analysts' expectations of $16.66 million. Medical Transcription Billing had a negative net margin of 6.62% and a negative return on equity of 8.26%. View Medical Transcription Billing's Earnings History.

When is Medical Transcription Billing's next earnings date?

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Medical Transcription Billing.

What guidance has Medical Transcription Billing issued on next quarter's earnings?

Medical Transcription Billing issued an update on its FY 2018 earnings guidance on Wednesday, November, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $49-50 million, compared to the consensus revenue estimate of $43.8 million.

What price target have analysts set for MTBC?

3 Wall Street analysts have issued 1 year price targets for Medical Transcription Billing's stock. Their forecasts range from $2.75 to $6.00. On average, they expect Medical Transcription Billing's share price to reach $4.3750 in the next twelve months. This suggests that the stock has a possible downside of 2.3%. View Analyst Price Targets for Medical Transcription Billing.

What is the consensus analysts' recommendation for Medical Transcription Billing?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Has Medical Transcription Billing been receiving favorable news coverage?

News coverage about MTBC stock has trended negative on Wednesday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a news impact score of -2.5 on InfoTrie's scale. They also gave media stories about the technology company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near term.

Who are some of Medical Transcription Billing's key competitors?

How do I buy shares of Medical Transcription Billing?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medical Transcription Billing's stock price today?

One share of MTBC stock can currently be purchased for approximately $4.48.

How big of a company is Medical Transcription Billing?

Medical Transcription Billing has a market capitalization of $53.23 million and generates $31.81 million in revenue each year. The technology company earns $-5,560,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis. Medical Transcription Billing employs 1,700 workers across the globe.

What is Medical Transcription Billing's official website?

The official website for Medical Transcription Billing is

How can I contact Medical Transcription Billing?

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.

MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  178 (Vote Underperform)
Total Votes:  330
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel